Browse by Poster Presenter

Skip to main content

ISOP ACoP 2025 Annual Conference Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

C
Caratzas, Eleni

Janssen RnD
(M-048) Development of a whole-body physiologically-based pharmacokinetic (PBPK) model for large molecule FcRn inhibitors in pregnancy incorporating placental transfer
Eleni Caratzas
Favorite
Cave, Joseph

Weill Cornell Medicine; Houston Methodist Research Institute
(S-093) Machine Learning-Integrated Physiology-Based Pharmacokinetic Modeling for Optimizing Nanoparticle Design
Joseph Cave
Favorite
Chacin Ruiz, Eduardo Andres

University at Buffalo, The State University of New York
(S-054) Computer Modeling of Bevacizumab Drug Distribution After Intravitreal Injection in Rabbit and Human Eyes
Eduardo Andres Chacin Ruiz
Favorite
Chakravarty, Arijit

Fractal Therapeutics
(S-009) A novel approach for predicting the efficacy of updated vaccines when the correlate of protection is known
Arijit Chakravarty
Favorite
(S-010) Bayesian modeling allows early inference of pharmacokinetic/pharmacodynamic relationship for a novel small molecule STING agonist in Phase I
Arijit Chakravarty
Favorite
(S-116) A Novel Bayesian Adaptive Design for Phase I Dose Escalation with Improved Efficiency and Accuracy in Estimation of Maximum Tolerated Dose
Arijit Chakravarty
Favorite
Chamzas, Athanasios

University of Maryland School of Pharmacy
(T-104) Population Pharmacokinetics of Dexmedetomidine in Neonates with Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia: Insights from a Prospective Real-World Study
Athanasios Chamzas
Favorite
Chandra, Fiona

Amgen
(T-088) A Mechanistic Pharmacokinetic/Pharmacodynamic Model for CD19 Targeting Therapies for Autoimmune Diseases
Fiona Chandra
Favorite
Chang, Jason

Genentech/Johns Hopkins University
(T-091) gQSPTwin: A MATLAB-Based Application for Automation and Standardization of the QSP Digital Twin Generation Workflow
Jason Chang
Favorite
CHARBE, NITIN

Indiana University School of Medicine, Indianapolis, IN, USA
(T-105) Characterizing Chimeric Aducanumab Disposition in a Preclinical Alzheimer’s Model Using Population PK Modeling
NITIN CHARBE
Favorite
Chauvin, Jonathan

Simulations Plus
(S-072) Automated concentration-QT data preparation, model selection and reporting in R
Jonathan Chauvin
Favorite
Checchio, Tina

Pfizer
(M-016) Application of in silico Healthy Control Cohorts in the Analysis of Osivelotor Exposure in Organ Impairment
Tina Checchio
Favorite
Cheng, Limei

Incyte Corporation
(M-057) Quantitative Systems Pharmacology Modeling to Support First-in-Human Dose Selection for a CD3 Bispecific Antibody in B-Cell Lymphoma and Renal Cell Carcinoma
Limei Cheng
Favorite
(S-012) A Minimal-Quantitative Systems Pharmacology Model for Dual-Targeting Bispecific T Cell Modulators in Immuno-Oncology for Solid Tumors
Limei Cheng
Favorite
Cheng, Shen

College of Pharmacy, University of Minnesota
(M-065) Pharmacometrics and Machine Learning-Based Modeling to Assess the Impact of Vaginal Microbiome on Tenofovir Exposures in the Female Genital Tract of African Women
Shen Cheng
Favorite
Chen, Huili

Pfizer
(M-110) Re-evaluation of Fixed dosing versus Body Size-Based Dosing Approaches for Large Molecule Therapeutics in Adults
Huili Chen
Favorite
Chen, Po-Wei

Amgen Inc.
(S-027) Implementation of Efron Correction for Tied-time Records in Time-variant and Time-invariant Cox Proportional Hazard Model in NONMEM
Po-Wei Chen
Favorite
Chen, Wenbo

Merck & Co., Inc.
(S-033) The Dose and Dosing Schedule Selection for an Investigational Immuno-Oncology Drug Based on a Pharmacokinetics and Pharmacodynamic Model of Tolerance
Wenbo Chen
Favorite
Chen, Xinyue

University of Florida
(S-038) A Physiologically Based Pharmacokinetic Model of Ceftriaxone in Healthy Adults and Pregnant Women
Xinyue Chen
Favorite
Chen, Yinbo

Bristol Myers Squibb
(M-013) QSP Model of Nivolumab in Combination with Bispecific T Cell Engagers predicts Enhanced Anti-Tumor Immunity
Yinbo Chen
Favorite
Cho, Yu Kyoung

Johnson and Johnson Innovative Medicine
(T-062) Exposure-Response Analysis of Guselkumab in the Maintenance Phase in Adults with Moderately to Severely Active Ulcerative Colitis
Yu Kyoung Cho
Favorite
Chung, Douglas

Certara Applied BioSimulation, Sheffield, United Kingdom
(M-059) Investigating the Role of Epithelial Barrier Function in Inflammatory Bowel Disease with Mechanistic Modeling
Douglas Chung
Favorite
Clark, Elias

Metrum Research Group
(M-104) Comparison of $PRED and $DES in NONMEM for time-varying categorical covariates in disease progression modeling.
Elias Clark
Favorite
Clary, James

Allucent, LLC
(M-029) Bayesian Analysis of Nonclinical Studies to Inform Regimen Selection for Tuberculosis
James Clary
Favorite
(T-022) Using Population Pharmacokinetics and Simulation to Develop SAT-3247 for the Treatment of Duchenne Muscular Dystrophy in Pediatric Patients
James Clary
Favorite
Cogny, Frederic

Nova In Silico
(M-025) Enhancing Model Interoperability and Workflow Integration in Clinical Trial Simulations
Frederic Cogny
Favorite
(M-026) Enhancing Clinical Trial Simulations with Advanced Computational Techniques and Scalable Cloud Solutions
Frederic Cogny
Favorite
(S-029) Supporting ICH M15 Principles Through a Collaborative Platform for Good Simulation Practices
Frederic Cogny
Favorite
(S-030) Automated Generation of Computational Models from Scientific Publications Using AI
Frederic Cogny
Favorite
(T-023) Optimizing Clinical Trial Design through In Silico Modeling, Virtual Populations, and Mathematical Optimization
Frederic Cogny
Favorite
(T-024) A Scalable, Traceable and Integrated Tool for Large QSP Models Calibration
Frederic Cogny
Favorite
Conchon Costa, Ana Carolina

University of Florida / Certara
(T-020) Comparison of Machine Learning and traditional Population Pharmacokinetic of Gabapentin in Neuropathic Pain
Ana Carolina Conchon Costa
Favorite
Cong, Shuangchen

Pfizer Pharmaceutical Ltd., Development China
(T-049) Monte-Carlo simulations to assess isavuconazole probability of pharmacokinetic-pharmacodynamic target attainment (PTA) for Chinese pediatric patients with invasive aspergillosis (IA) or invasive mucormycosis (IM)
Shuangchen Cong
Favorite
Contento, Lorenzo

Pumas-AI Inc.
(S-068) Machine learning for exploratory data analysis and model diagnosis in oncology
Lorenzo Contento
Favorite
Cruikshank, Allison

Duke University
(S-085) Investigating the Role of Estradiol in Oxidative Stress in Health and Disease: A Mechanistic Model
Allison Cruikshank
Favorite
Cui, Zihan

Critical Path Institute
(T-040) Disease progression model for TKV and eGFR prediction in patients with autosomal dominant polycystic kidney disease
Zihan Cui
Favorite